Search results for: 'Preferred Destination for Early Phase Clinical Trials'

The Affordable Care Act has created an upswing in the number of patients entering the US healthcare system, boosting the volume of routine and specialized testing performed in laboratories. This market insight analyzes the instrumentation and reagent segment activity within the US hemostasis market. Key trends and a comparative analysis between the...